imagine a congressional hearing held before media cameras, with reporters all over the us and europe ready with shocking articles about one of the leading causes of death�. 1.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
loading more comments
.
us opioid crisis hits indian pharma companies
.treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk (file pic)..